ISRG three-lens brief
Evidence-based stock research on ISRG. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 20.3pp over 30 days. · Trading at 6% of its 52-week range — deep in the lower band.
- Trading at 6% of its 52-week range — deep in the lower band.
- Underperforming SPY by 20.3pp over 30 days.
- Analyst mean target $576.91 — 35% above current (29 analysts).
ISRG closed at $428.89 (-0.69%) as of 2026-05-13. Market cap: $151.90B. P/E (trailing) 52.0. Positives: analyst mean target $576.91 — 35% above current (29 analysts).. Concerns: trading at 6% of its 52-week range — deep in the lower band.; underperforming SPY by 20.3pp over 30 days.. Last quarter: Revenue $2.77B, net income $821.50M, free cash flow $2.25B.
Why three lenses on ISRG, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ISRGacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ISRG" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ISRG brief"></iframe>